Table 1 Clinicopathological characteristics by histotype of the 6434 OC patients, with complete survival data, analysed for FOXJ1 protein expression.

From: Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

Characteristic

HGSC

LGSC

MC

EC

CCC

Number of cases, n (%)a

4634 (72.0)

178 (2.8)

256 (4.0)

746 (11.6)

620 (9.6)

Age at diagnosis, years

 Mean ± SD

60.6 ± 10.7

54.9 ± 12.5

53.2 ± 14.8

55.1 ± 11.7

56.2 ± 11.5

 Median

61

55

53

54

56

 Range

21–93

23–88

23–95

22–88

27–91

Stage, n (%)b

 FIGO I, II (localised)

846 (18.3)

54 (30.3)

216 (84.4)

625 (83.8)

473 (76.3)

 FIGO III, IV (distant)

3788 (81.7)

124 (69.7)

40 (15.6)

121 (16.2)

147 (23.7)

Outcomec

 Alive, n (%)b

1361 (29.4)

78 (43.8)

167 (65.2)

536 (71.9)

345 (55.7)

 Dead, n (%)b

3273 (70.6)

100 (56.2)

89 (34.8)

210 (28.2)

275 (44.4)

 5-year survival, % ± SE

39.0 ± 0.75

59.8 ± 4.1

67.0 ± 3.2

81.3 ± 1.6

61.5 ± 2.1

  1. CCC clear cell ovarian carcinoma, EC endometroid ovarian carcinoma, HGSC high-grade serous ovarian carcinoma, FIGO International Federation of Gynecology and Obstetrics, LGSC low-grade serous ovarian carcinoma, MC mucinous ovarian carcinoma, SD standard deviation, SE standard error.
  2. aThe proportion of cases in each histotypes is given as a percentage of the total patients examined.
  3. bThe proportion of cases is given as a percentage of the total cases within each histotypes.
  4. cFinal status of the patient, being alive or dead, at 10 years, following enrollment in an OTTA study.
Back to article page